2',3'-Dideoxyuridine triphosphate conjugated to SiO2 nanoparticles: Synthesis and evaluation of antiproliferative activity

Bioorg Med Chem Lett. 2018 Apr 15;28(7):1248-1251. doi: 10.1016/j.bmcl.2018.02.007. Epub 2018 Feb 7.

Abstract

A conjugate of triphosphorylated 2',3'-dideoxyuridine (ddU) with SiO2 nanoparticles was obtained via the CuAAC click chemistry between a γ-alkynyl ddU triphosphate and azido-modified SiO2 nanoparticles. Assessment of cytotoxicity in human breast adenocarcinoma MCF7 cells demonstrated that ddU triphosphate conjugated to SiO2 nanoparticles exhibited a 50% decrease in cancer cell growth at a concentration of 183 ± 57 µg/mL, which corresponds to 22 ± 7 µM of the parent nucleotide, whereas the parent nucleoside, nucleotide and alkynyl triphosphate precursor do not show any cytotoxicity. The data provide an example of remarkable potential of novel conjugates of SiO2 nanoparticles with phosphorylated nucleoside analogues, even those, which have not been used previously as therapeutics, for application as new anticancer agents.

Keywords: 2′, 3′-Dideoxyuridine triphosphate; CuAAC; Cytotoxicity; MCF7 cells; SiO(2) nanoparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Dideoxynucleotides / chemical synthesis
  • Dideoxynucleotides / chemistry
  • Dideoxynucleotides / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • MCF-7 Cells
  • Molecular Structure
  • Nanoparticles / chemistry*
  • Silicon Dioxide / chemistry
  • Silicon Dioxide / pharmacology*
  • Structure-Activity Relationship
  • Uracil Nucleotides / chemical synthesis
  • Uracil Nucleotides / chemistry
  • Uracil Nucleotides / pharmacology*

Substances

  • Antineoplastic Agents
  • Dideoxynucleotides
  • Uracil Nucleotides
  • Silicon Dioxide
  • 2',3'-dideoxyuridine-5'-triphosphate